Thursday, October 2, 2014

EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources

By Foo Yun Chee

BRUSSELS (Reuters) – EU antitrust regulators will open an extensive probe into Zimmer Holdings Inc’s $13.4 billion bid for Biomet Inc, concerned that the creation of the world’s second-largest orthopedic products group may hurt…

EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources




No comments:

Post a Comment